PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ebf1
|
ENSMUSG00000057098.15 | Ebf1 |
Ebf1
|
ENSMUSG00000057098.15 | Ebf1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Ebf1 | mm39_v1_chr11_+_44508137_44508169 | -0.01 | 9.6e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_-_134975773 | 12.32 |
ENSMUST00000051401.4
|
Cldn4
|
claudin 4 |
chr16_-_97412169 | 11.03 |
ENSMUST00000232141.2
ENSMUST00000000395.8 |
Tmprss2
|
transmembrane protease, serine 2 |
chr17_+_34482183 | 10.29 |
ENSMUST00000040828.7
ENSMUST00000237342.2 ENSMUST00000237866.2 |
H2-Ab1
|
histocompatibility 2, class II antigen A, beta 1 |
chr11_-_102255999 | 8.85 |
ENSMUST00000006749.10
|
Slc4a1
|
solute carrier family 4 (anion exchanger), member 1 |
chr5_-_100710702 | 8.15 |
ENSMUST00000097437.9
|
Plac8
|
placenta-specific 8 |
chr11_+_96820220 | 8.02 |
ENSMUST00000062172.6
|
Prr15l
|
proline rich 15-like |
chr17_+_48666919 | 7.81 |
ENSMUST00000224001.2
ENSMUST00000024792.8 ENSMUST00000225849.2 |
Treml1
|
triggering receptor expressed on myeloid cells-like 1 |
chr11_+_96820091 | 7.79 |
ENSMUST00000054311.6
ENSMUST00000107636.4 |
Prr15l
|
proline rich 15-like |
chr11_-_100036792 | 7.37 |
ENSMUST00000007317.8
|
Krt19
|
keratin 19 |
chr8_+_84682136 | 7.36 |
ENSMUST00000005607.9
|
Asf1b
|
anti-silencing function 1B histone chaperone |
chr18_+_60936910 | 7.34 |
ENSMUST00000097563.9
ENSMUST00000050487.16 ENSMUST00000167610.2 |
Cd74
|
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) |
chr7_+_24069680 | 7.33 |
ENSMUST00000205428.2
ENSMUST00000171904.3 ENSMUST00000205626.2 |
Kcnn4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
chr16_-_97306125 | 7.04 |
ENSMUST00000049721.9
ENSMUST00000231999.2 |
Fam3b
|
family with sequence similarity 3, member B |
chr16_-_97564910 | 6.96 |
ENSMUST00000019386.10
|
Ripk4
|
receptor-interacting serine-threonine kinase 4 |
chr17_+_36176485 | 6.92 |
ENSMUST00000127442.8
ENSMUST00000144382.8 |
Ppp1r18
|
protein phosphatase 1, regulatory subunit 18 |
chr17_+_35413415 | 6.63 |
ENSMUST00000025262.6
ENSMUST00000173600.2 |
Ltb
|
lymphotoxin B |
chr8_-_71219299 | 6.57 |
ENSMUST00000222087.4
|
Ifi30
|
interferon gamma inducible protein 30 |
chr2_+_84810802 | 6.47 |
ENSMUST00000028467.6
|
Prg2
|
proteoglycan 2, bone marrow |
chr6_+_68247469 | 6.46 |
ENSMUST00000103321.3
|
Igkv1-110
|
immunoglobulin kappa variable 1-110 |
chr3_+_10431961 | 6.46 |
ENSMUST00000029049.7
|
Chmp4c
|
charged multivesicular body protein 4C |
chr5_+_136996713 | 6.45 |
ENSMUST00000001790.6
|
Cldn15
|
claudin 15 |
chr18_-_35782412 | 6.42 |
ENSMUST00000025211.6
|
Mzb1
|
marginal zone B and B1 cell-specific protein 1 |
chr10_-_84938350 | 6.42 |
ENSMUST00000059383.8
ENSMUST00000216889.2 |
Fhl4
|
four and a half LIM domains 4 |
chr8_-_106863521 | 6.31 |
ENSMUST00000115979.9
|
Esrp2
|
epithelial splicing regulatory protein 2 |
chr7_-_79882313 | 6.22 |
ENSMUST00000206084.2
ENSMUST00000205996.2 ENSMUST00000071457.12 |
Cib1
|
calcium and integrin binding 1 (calmyrin) |
chr19_-_3736549 | 6.22 |
ENSMUST00000025856.17
ENSMUST00000176867.2 |
Lrp5
|
low density lipoprotein receptor-related protein 5 |
chr9_+_62765362 | 6.21 |
ENSMUST00000213643.2
ENSMUST00000034777.14 ENSMUST00000163820.3 ENSMUST00000215870.2 ENSMUST00000214633.2 ENSMUST00000215968.2 |
Calml4
|
calmodulin-like 4 |
chr6_+_55313409 | 6.18 |
ENSMUST00000004774.4
|
Aqp1
|
aquaporin 1 |
chr16_-_19060440 | 6.15 |
ENSMUST00000103751.3
|
Iglv3
|
immunoglobulin lambda variable 3 |
chr15_+_99489018 | 5.93 |
ENSMUST00000229728.2
ENSMUST00000231163.2 |
Aqp5
|
aquaporin 5 |
chr5_-_139798992 | 5.88 |
ENSMUST00000110832.8
|
Tmem184a
|
transmembrane protein 184a |
chr15_+_80507671 | 5.51 |
ENSMUST00000043149.9
|
Grap2
|
GRB2-related adaptor protein 2 |
chr17_+_36176948 | 5.39 |
ENSMUST00000122899.8
|
Ppp1r18
|
protein phosphatase 1, regulatory subunit 18 |
chr6_-_55152002 | 5.39 |
ENSMUST00000003569.6
|
Inmt
|
indolethylamine N-methyltransferase |
chr7_+_100142544 | 5.29 |
ENSMUST00000126534.8
ENSMUST00000207748.2 |
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr11_-_116585627 | 5.26 |
ENSMUST00000079545.6
|
St6galnac2
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 |
chr9_-_109678685 | 5.25 |
ENSMUST00000112022.5
|
Camp
|
cathelicidin antimicrobial peptide |
chr1_+_171246593 | 5.18 |
ENSMUST00000171362.2
|
Tstd1
|
thiosulfate sulfurtransferase (rhodanese)-like domain containing 1 |
chr11_+_69856222 | 5.16 |
ENSMUST00000018713.13
|
Cldn7
|
claudin 7 |
chr7_+_118232952 | 5.13 |
ENSMUST00000057320.8
|
Tmc5
|
transmembrane channel-like gene family 5 |
chr10_+_11157047 | 5.10 |
ENSMUST00000129456.8
|
Fbxo30
|
F-box protein 30 |
chr6_-_48747767 | 5.01 |
ENSMUST00000204036.2
|
Gimap3
|
GTPase, IMAP family member 3 |
chr2_+_119067929 | 5.00 |
ENSMUST00000110816.8
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr2_+_119068012 | 5.00 |
ENSMUST00000110817.3
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr6_-_136638926 | 5.00 |
ENSMUST00000032336.7
|
Plbd1
|
phospholipase B domain containing 1 |
chr4_-_129436465 | 4.98 |
ENSMUST00000102597.5
|
Hdac1
|
histone deacetylase 1 |
chr14_+_54429757 | 4.96 |
ENSMUST00000103714.2
|
Traj27
|
T cell receptor alpha joining 27 |
chr11_+_88890202 | 4.93 |
ENSMUST00000100627.9
ENSMUST00000107896.10 ENSMUST00000000284.7 |
Trim25
|
tripartite motif-containing 25 |
chr17_+_34816826 | 4.89 |
ENSMUST00000015596.10
ENSMUST00000174496.9 ENSMUST00000173992.8 |
Ager
|
advanced glycosylation end product-specific receptor |
chr7_+_126690525 | 4.84 |
ENSMUST00000056288.7
ENSMUST00000206102.2 |
AI467606
|
expressed sequence AI467606 |
chr6_+_135042649 | 4.82 |
ENSMUST00000050104.8
|
Gprc5a
|
G protein-coupled receptor, family C, group 5, member A |
chr7_+_67925718 | 4.81 |
ENSMUST00000210558.2
|
Fam169b
|
family with sequence similarity 169, member B |
chr12_-_84923252 | 4.80 |
ENSMUST00000163189.8
ENSMUST00000110254.9 ENSMUST00000002073.13 |
Ltbp2
|
latent transforming growth factor beta binding protein 2 |
chr6_+_17463748 | 4.73 |
ENSMUST00000115443.8
|
Met
|
met proto-oncogene |
chr2_-_93292800 | 4.71 |
ENSMUST00000028644.11
|
Cd82
|
CD82 antigen |
chr14_+_30853010 | 4.71 |
ENSMUST00000227096.2
|
Nt5dc2
|
5'-nucleotidase domain containing 2 |
chr15_-_10713621 | 4.69 |
ENSMUST00000090339.11
|
Rai14
|
retinoic acid induced 14 |
chr6_-_124519240 | 4.64 |
ENSMUST00000159463.8
ENSMUST00000162844.2 ENSMUST00000160505.8 ENSMUST00000162443.8 |
C1s1
|
complement component 1, s subcomponent 1 |
chr2_-_32277773 | 4.64 |
ENSMUST00000050785.14
|
Lcn2
|
lipocalin 2 |
chr17_+_44499451 | 4.61 |
ENSMUST00000024755.7
|
Clic5
|
chloride intracellular channel 5 |
chr6_-_83654789 | 4.55 |
ENSMUST00000037882.8
|
Cd207
|
CD207 antigen |
chr7_-_28078671 | 4.55 |
ENSMUST00000209061.2
|
Zfp36
|
zinc finger protein 36 |
chr12_-_113575237 | 4.54 |
ENSMUST00000178229.3
|
Ighv2-3
|
immunoglobulin heavy variable 2-3 |
chr13_+_73911797 | 4.53 |
ENSMUST00000017900.9
|
Slc12a7
|
solute carrier family 12, member 7 |
chr17_-_34736326 | 4.52 |
ENSMUST00000075483.5
|
Btnl6
|
butyrophilin-like 6 |
chr8_-_106863423 | 4.51 |
ENSMUST00000146940.2
|
Esrp2
|
epithelial splicing regulatory protein 2 |
chr10_+_43455919 | 4.51 |
ENSMUST00000214476.2
|
Cd24a
|
CD24a antigen |
chr17_-_56819422 | 4.51 |
ENSMUST00000052211.4
|
Znrf4
|
zinc and ring finger 4 |
chr2_-_126341757 | 4.48 |
ENSMUST00000040128.12
|
Atp8b4
|
ATPase, class I, type 8B, member 4 |
chr4_-_152213315 | 4.45 |
ENSMUST00000049305.14
|
Espn
|
espin |
chr17_+_37180437 | 4.43 |
ENSMUST00000060524.11
|
Trim10
|
tripartite motif-containing 10 |
chr15_-_78456898 | 4.42 |
ENSMUST00000043214.8
|
Rac2
|
Rac family small GTPase 2 |
chr10_+_79855454 | 4.41 |
ENSMUST00000043311.7
|
Arhgap45
|
Rho GTPase activating protein 45 |
chr4_+_126042250 | 4.39 |
ENSMUST00000106150.3
|
Eva1b
|
eva-1 homolog B (C. elegans) |
chr7_+_24310738 | 4.39 |
ENSMUST00000073325.6
|
Phldb3
|
pleckstrin homology like domain, family B, member 3 |
chr10_+_81228877 | 4.39 |
ENSMUST00000105322.9
|
Smim24
|
small integral membrane protein 24 |
chr2_+_131028861 | 4.38 |
ENSMUST00000028804.15
ENSMUST00000079857.9 |
Cdc25b
|
cell division cycle 25B |
chr6_-_86770504 | 4.36 |
ENSMUST00000204441.3
ENSMUST00000204398.2 ENSMUST00000001187.15 |
Anxa4
|
annexin A4 |
chr7_-_19530714 | 4.36 |
ENSMUST00000108449.9
ENSMUST00000043822.8 |
Cblc
|
Casitas B-lineage lymphoma c |
chr2_+_84670956 | 4.34 |
ENSMUST00000111625.2
|
Slc43a1
|
solute carrier family 43, member 1 |
chr11_-_69786324 | 4.27 |
ENSMUST00000001631.7
|
Acap1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr1_-_74163575 | 4.27 |
ENSMUST00000169786.8
ENSMUST00000212888.2 ENSMUST00000191104.7 |
Tns1
|
tensin 1 |
chr7_+_28136861 | 4.26 |
ENSMUST00000108292.9
ENSMUST00000108289.8 |
Gmfg
|
glia maturation factor, gamma |
chr4_-_41098174 | 4.25 |
ENSMUST00000055327.8
|
Aqp3
|
aquaporin 3 |
chr11_-_116001037 | 4.25 |
ENSMUST00000106441.8
ENSMUST00000021120.6 |
Trim47
|
tripartite motif-containing 47 |
chr11_+_115790768 | 4.25 |
ENSMUST00000152171.8
|
Smim5
|
small integral membrane protein 5 |
chr3_+_68912302 | 4.23 |
ENSMUST00000136502.8
ENSMUST00000107803.7 |
Smc4
|
structural maintenance of chromosomes 4 |
chr6_-_69282389 | 4.21 |
ENSMUST00000103350.3
|
Igkv4-68
|
immunoglobulin kappa variable 4-68 |
chr7_-_79882501 | 4.20 |
ENSMUST00000065163.15
|
Cib1
|
calcium and integrin binding 1 (calmyrin) |
chr1_+_172328768 | 4.15 |
ENSMUST00000111228.2
|
Tagln2
|
transgelin 2 |
chr7_+_100970435 | 4.11 |
ENSMUST00000210192.2
ENSMUST00000172630.8 |
Stard10
|
START domain containing 10 |
chr10_+_69048464 | 4.11 |
ENSMUST00000020101.12
|
Rhobtb1
|
Rho-related BTB domain containing 1 |
chr12_+_8821404 | 4.09 |
ENSMUST00000171158.8
|
Sdc1
|
syndecan 1 |
chr9_+_108867633 | 4.08 |
ENSMUST00000112059.10
ENSMUST00000026737.12 |
Shisa5
|
shisa family member 5 |
chr12_+_8821317 | 4.07 |
ENSMUST00000020911.14
|
Sdc1
|
syndecan 1 |
chr11_+_3981769 | 4.06 |
ENSMUST00000019512.8
|
Sec14l4
|
SEC14-like lipid binding 4 |
chr7_+_100970910 | 4.04 |
ENSMUST00000174291.8
ENSMUST00000167888.9 ENSMUST00000172662.2 |
Stard10
|
START domain containing 10 |
chr7_-_44181477 | 4.03 |
ENSMUST00000098483.9
ENSMUST00000035323.6 |
Spib
|
Spi-B transcription factor (Spi-1/PU.1 related) |
chr1_-_119576347 | 4.00 |
ENSMUST00000027632.14
ENSMUST00000187194.2 |
Epb41l5
|
erythrocyte membrane protein band 4.1 like 5 |
chr10_+_75242745 | 3.98 |
ENSMUST00000039925.8
|
Upb1
|
ureidopropionase, beta |
chr1_+_131678223 | 3.97 |
ENSMUST00000147800.2
|
Slc26a9
|
solute carrier family 26, member 9 |
chr10_+_11157326 | 3.96 |
ENSMUST00000070300.5
|
Fbxo30
|
F-box protein 30 |
chr10_+_110581293 | 3.94 |
ENSMUST00000174857.8
ENSMUST00000073781.12 ENSMUST00000173471.8 ENSMUST00000173634.2 |
E2f7
|
E2F transcription factor 7 |
chr6_+_43242516 | 3.93 |
ENSMUST00000031750.14
|
Arhgef5
|
Rho guanine nucleotide exchange factor (GEF) 5 |
chrX_+_149330371 | 3.93 |
ENSMUST00000066337.13
ENSMUST00000112715.2 |
Alas2
|
aminolevulinic acid synthase 2, erythroid |
chr6_+_68098030 | 3.92 |
ENSMUST00000103317.3
|
Igkv1-117
|
immunoglobulin kappa variable 1-117 |
chr4_+_135413593 | 3.90 |
ENSMUST00000074408.7
|
Ifnlr1
|
interferon lambda receptor 1 |
chr5_+_42225303 | 3.89 |
ENSMUST00000087332.5
|
Gm16223
|
predicted gene 16223 |
chr16_-_96244794 | 3.89 |
ENSMUST00000113773.2
ENSMUST00000000161.14 |
Itgb2l
|
integrin beta 2-like |
chr11_-_72302520 | 3.87 |
ENSMUST00000108500.8
ENSMUST00000050226.7 |
Smtnl2
|
smoothelin-like 2 |
chr7_+_87927293 | 3.87 |
ENSMUST00000032779.12
ENSMUST00000131108.9 ENSMUST00000128791.2 |
Ctsc
|
cathepsin C |
chr1_-_90897329 | 3.84 |
ENSMUST00000130042.2
ENSMUST00000027529.12 |
Rab17
|
RAB17, member RAS oncogene family |
chr2_-_75534985 | 3.83 |
ENSMUST00000102672.5
|
Nfe2l2
|
nuclear factor, erythroid derived 2, like 2 |
chr4_+_134123631 | 3.83 |
ENSMUST00000105869.9
|
Pafah2
|
platelet-activating factor acetylhydrolase 2 |
chr12_+_59177780 | 3.82 |
ENSMUST00000177460.8
|
Mia2
|
MIA SH3 domain ER export factor 2 |
chr8_+_107237483 | 3.81 |
ENSMUST00000080797.8
|
Cdh3
|
cadherin 3 |
chr6_+_40605758 | 3.81 |
ENSMUST00000202636.4
ENSMUST00000201148.4 ENSMUST00000071535.10 |
Mgam
|
maltase-glucoamylase |
chr3_-_82811269 | 3.80 |
ENSMUST00000029632.7
|
Lrat
|
lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase) |
chr2_+_84670543 | 3.80 |
ENSMUST00000111624.8
|
Slc43a1
|
solute carrier family 43, member 1 |
chr2_+_70339832 | 3.80 |
ENSMUST00000153121.2
|
Erich2
|
glutamate rich 2 |
chrX_+_35375751 | 3.79 |
ENSMUST00000033418.8
|
Il13ra1
|
interleukin 13 receptor, alpha 1 |
chr5_-_18054781 | 3.79 |
ENSMUST00000170051.8
|
Cd36
|
CD36 molecule |
chr16_-_10609959 | 3.78 |
ENSMUST00000037996.7
|
Prm2
|
protamine 2 |
chrX_-_7834057 | 3.78 |
ENSMUST00000033502.14
|
Gata1
|
GATA binding protein 1 |
chr7_+_30673212 | 3.78 |
ENSMUST00000129773.2
|
Fam187b
|
family with sequence similarity 187, member B |
chr19_+_4036562 | 3.78 |
ENSMUST00000236224.2
ENSMUST00000236510.2 ENSMUST00000237910.2 ENSMUST00000235612.2 ENSMUST00000054030.8 |
Acy3
|
aspartoacylase (aminoacylase) 3 |
chr7_-_30672824 | 3.76 |
ENSMUST00000147431.2
ENSMUST00000098553.11 ENSMUST00000108116.10 |
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr12_-_17050109 | 3.76 |
ENSMUST00000054536.11
|
Pqlc3
|
PQ loop repeat containing |
chr5_-_18054702 | 3.75 |
ENSMUST00000165232.8
|
Cd36
|
CD36 molecule |
chr7_-_140590605 | 3.75 |
ENSMUST00000026565.7
|
Ifitm3
|
interferon induced transmembrane protein 3 |
chr4_+_135975243 | 3.73 |
ENSMUST00000102533.11
ENSMUST00000143942.2 |
Tcea3
|
transcription elongation factor A (SII), 3 |
chr18_-_62313019 | 3.72 |
ENSMUST00000053640.5
|
Adrb2
|
adrenergic receptor, beta 2 |
chr15_+_99488527 | 3.72 |
ENSMUST00000169082.3
ENSMUST00000088200.13 |
Aqp5
|
aquaporin 5 |
chr1_+_172302925 | 3.68 |
ENSMUST00000027830.5
|
Slamf9
|
SLAM family member 9 |
chr1_+_131898325 | 3.67 |
ENSMUST00000027695.8
|
Slc45a3
|
solute carrier family 45, member 3 |
chr17_-_43187280 | 3.67 |
ENSMUST00000024709.9
ENSMUST00000233476.2 |
Cd2ap
|
CD2-associated protein |
chr15_-_54953819 | 3.67 |
ENSMUST00000110231.2
ENSMUST00000023059.13 |
Dscc1
|
DNA replication and sister chromatid cohesion 1 |
chr19_-_10716335 | 3.66 |
ENSMUST00000025571.9
ENSMUST00000238167.2 |
Cd5
|
CD5 antigen |
chr14_-_69522431 | 3.66 |
ENSMUST00000183882.2
ENSMUST00000037064.5 |
Slc25a37
|
solute carrier family 25, member 37 |
chr2_-_93292734 | 3.65 |
ENSMUST00000099696.8
|
Cd82
|
CD82 antigen |
chr17_+_35658131 | 3.65 |
ENSMUST00000071951.14
ENSMUST00000116598.10 ENSMUST00000078205.14 ENSMUST00000076256.8 |
H2-Q7
|
histocompatibility 2, Q region locus 7 |
chr10_-_128237087 | 3.64 |
ENSMUST00000042666.13
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr3_+_146205864 | 3.62 |
ENSMUST00000119130.2
|
Gng5
|
guanine nucleotide binding protein (G protein), gamma 5 |
chr19_-_9065309 | 3.62 |
ENSMUST00000025554.3
|
Scgb1a1
|
secretoglobin, family 1A, member 1 (uteroglobin) |
chr15_+_75468473 | 3.62 |
ENSMUST00000189944.7
ENSMUST00000023243.11 |
Gpihbp1
|
GPI-anchored HDL-binding protein 1 |
chr9_-_110572694 | 3.59 |
ENSMUST00000196057.2
|
Pth1r
|
parathyroid hormone 1 receptor |
chr3_-_94693780 | 3.59 |
ENSMUST00000107273.9
ENSMUST00000238849.2 |
Cgn
|
cingulin |
chr10_-_81127057 | 3.58 |
ENSMUST00000045744.7
|
Tjp3
|
tight junction protein 3 |
chr7_-_30672889 | 3.57 |
ENSMUST00000001279.15
|
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr11_+_83007635 | 3.57 |
ENSMUST00000037994.8
|
Slfn1
|
schlafen 1 |
chr17_+_47747540 | 3.56 |
ENSMUST00000037701.13
|
AI661453
|
expressed sequence AI661453 |
chr8_-_27664651 | 3.56 |
ENSMUST00000054212.7
ENSMUST00000033878.14 ENSMUST00000209377.2 |
Rab11fip1
|
RAB11 family interacting protein 1 (class I) |
chr1_+_159871943 | 3.56 |
ENSMUST00000163892.8
|
4930523C07Rik
|
RIKEN cDNA 4930523C07 gene |
chr19_+_4204605 | 3.55 |
ENSMUST00000061086.9
|
Ptprcap
|
protein tyrosine phosphatase, receptor type, C polypeptide-associated protein |
chr7_-_4774277 | 3.54 |
ENSMUST00000174409.2
|
Fam71e2
|
family with sequence similarity 71, member E2 |
chr7_-_25176959 | 3.53 |
ENSMUST00000098668.3
ENSMUST00000206687.2 ENSMUST00000206676.2 ENSMUST00000205308.2 ENSMUST00000098669.8 ENSMUST00000206171.2 ENSMUST00000098666.9 |
Ceacam1
|
carcinoembryonic antigen-related cell adhesion molecule 1 |
chr3_-_105908789 | 3.53 |
ENSMUST00000066319.8
|
Pifo
|
primary cilia formation |
chr4_-_133615075 | 3.53 |
ENSMUST00000003741.16
ENSMUST00000105894.11 |
Rps6ka1
|
ribosomal protein S6 kinase polypeptide 1 |
chr17_+_35598583 | 3.52 |
ENSMUST00000081435.5
|
H2-Q4
|
histocompatibility 2, Q region locus 4 |
chr9_-_110572721 | 3.51 |
ENSMUST00000166716.8
|
Pth1r
|
parathyroid hormone 1 receptor |
chr9_-_21671571 | 3.50 |
ENSMUST00000217382.2
ENSMUST00000214149.2 ENSMUST00000098942.6 ENSMUST00000216057.2 |
Spc24
|
SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
chr13_-_113237505 | 3.48 |
ENSMUST00000224282.2
ENSMUST00000023897.7 |
Gzma
|
granzyme A |
chr12_-_17049992 | 3.47 |
ENSMUST00000222203.2
|
Pqlc3
|
PQ loop repeat containing |
chr2_-_169973076 | 3.47 |
ENSMUST00000063710.13
|
Zfp217
|
zinc finger protein 217 |
chr6_-_37419030 | 3.46 |
ENSMUST00000041093.6
|
Creb3l2
|
cAMP responsive element binding protein 3-like 2 |
chr12_-_114672701 | 3.46 |
ENSMUST00000103505.3
ENSMUST00000193855.2 |
Ighv1-19
|
immunoglobulin heavy variable V1-19 |
chr2_-_60383647 | 3.45 |
ENSMUST00000112525.5
|
Pla2r1
|
phospholipase A2 receptor 1 |
chr2_+_152873772 | 3.45 |
ENSMUST00000037235.7
|
Xkr7
|
X-linked Kx blood group related 7 |
chr4_-_40853950 | 3.45 |
ENSMUST00000030121.13
ENSMUST00000108096.3 |
B4galt1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
chr18_+_70058533 | 3.45 |
ENSMUST00000043929.11
|
Ccdc68
|
coiled-coil domain containing 68 |
chr9_-_22041894 | 3.44 |
ENSMUST00000115315.3
|
Acp5
|
acid phosphatase 5, tartrate resistant |
chr17_-_84154173 | 3.44 |
ENSMUST00000000687.9
|
Haao
|
3-hydroxyanthranilate 3,4-dioxygenase |
chr12_-_4924341 | 3.44 |
ENSMUST00000137337.8
ENSMUST00000045921.14 |
Mfsd2b
|
major facilitator superfamily domain containing 2B |
chr4_-_138452517 | 3.42 |
ENSMUST00000105811.9
|
Ubxn10
|
UBX domain protein 10 |
chr10_+_69048506 | 3.41 |
ENSMUST00000167384.8
|
Rhobtb1
|
Rho-related BTB domain containing 1 |
chr17_-_7050145 | 3.41 |
ENSMUST00000064234.7
|
Ezr
|
ezrin |
chr12_-_113223839 | 3.39 |
ENSMUST00000194738.6
ENSMUST00000178282.3 |
Igha
|
immunoglobulin heavy constant alpha |
chr10_-_43880353 | 3.38 |
ENSMUST00000020017.14
|
Crybg1
|
crystallin beta-gamma domain containing 1 |
chr19_+_27299939 | 3.38 |
ENSMUST00000056708.4
|
Kcnv2
|
potassium channel, subfamily V, member 2 |
chr2_-_181101158 | 3.37 |
ENSMUST00000155535.2
ENSMUST00000029106.13 ENSMUST00000087409.10 |
Zbtb46
|
zinc finger and BTB domain containing 46 |
chr2_+_167922924 | 3.37 |
ENSMUST00000052125.7
|
Pard6b
|
par-6 family cell polarity regulator beta |
chr12_-_114252202 | 3.37 |
ENSMUST00000195124.6
ENSMUST00000103481.3 |
Ighv3-6
|
immunoglobulin heavy variable 3-6 |
chr3_+_87754310 | 3.36 |
ENSMUST00000029709.7
|
Sh2d2a
|
SH2 domain containing 2A |
chr6_-_73198608 | 3.36 |
ENSMUST00000064948.13
ENSMUST00000114040.8 |
Dnah6
|
dynein, axonemal, heavy chain 6 |
chr17_-_31363245 | 3.35 |
ENSMUST00000024826.8
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr15_+_78128990 | 3.35 |
ENSMUST00000096357.12
|
Ncf4
|
neutrophil cytosolic factor 4 |
chr15_-_82108531 | 3.35 |
ENSMUST00000109535.3
ENSMUST00000089161.10 |
Tnfrsf13c
|
tumor necrosis factor receptor superfamily, member 13c |
chr17_+_34416707 | 3.34 |
ENSMUST00000025196.9
|
Psmb8
|
proteasome (prosome, macropain) subunit, beta type 8 (large multifunctional peptidase 7) |
chr15_-_100534572 | 3.33 |
ENSMUST00000230280.2
|
Smagp
|
small cell adhesion glycoprotein |
chr4_+_148025316 | 3.33 |
ENSMUST00000103232.2
|
2510039O18Rik
|
RIKEN cDNA 2510039O18 gene |
chr15_-_100534733 | 3.31 |
ENSMUST00000066068.7
ENSMUST00000229965.2 ENSMUST00000172334.9 |
Smagp
|
small cell adhesion glycoprotein |
chr10_+_80165787 | 3.30 |
ENSMUST00000105358.8
ENSMUST00000105357.2 ENSMUST00000105354.8 ENSMUST00000105355.8 |
Reep6
|
receptor accessory protein 6 |
chr6_+_48661503 | 3.29 |
ENSMUST00000067506.14
ENSMUST00000119575.8 ENSMUST00000121957.8 ENSMUST00000090070.6 |
Gimap4
|
GTPase, IMAP family member 4 |
chr1_+_88128323 | 3.29 |
ENSMUST00000049289.9
|
Ugt1a2
|
UDP glucuronosyltransferase 1 family, polypeptide A2 |
chr4_+_133246274 | 3.28 |
ENSMUST00000149807.2
ENSMUST00000042919.16 ENSMUST00000153811.2 ENSMUST00000105901.2 ENSMUST00000121797.2 |
Kdf1
|
keratinocyte differentiation factor 1 |
chr7_-_140676596 | 3.28 |
ENSMUST00000209199.2
|
Sigirr
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
chr7_+_100971034 | 3.28 |
ENSMUST00000173270.8
|
Stard10
|
START domain containing 10 |
chr2_-_153083322 | 3.27 |
ENSMUST00000056924.14
|
Plagl2
|
pleiomorphic adenoma gene-like 2 |
chr5_+_103902020 | 3.26 |
ENSMUST00000054979.10
|
Aff1
|
AF4/FMR2 family, member 1 |
chr4_-_59549243 | 3.26 |
ENSMUST00000173699.8
ENSMUST00000173884.8 ENSMUST00000102883.11 ENSMUST00000174586.8 |
Ptbp3
|
polypyrimidine tract binding protein 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 10.5 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
3.4 | 10.3 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
3.3 | 13.2 | GO:0007113 | endomitotic cell cycle(GO:0007113) thrombopoietin-mediated signaling pathway(GO:0038163) |
3.1 | 9.3 | GO:0048627 | myoblast development(GO:0048627) |
2.9 | 8.6 | GO:1904753 | negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
2.8 | 13.9 | GO:0015793 | glycerol transport(GO:0015793) |
2.8 | 8.3 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
2.6 | 7.8 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
2.5 | 12.7 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
2.4 | 7.3 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
2.3 | 6.9 | GO:0002215 | defense response to nematode(GO:0002215) |
2.1 | 8.6 | GO:1902896 | terminal web assembly(GO:1902896) |
1.9 | 7.5 | GO:0035854 | eosinophil fate commitment(GO:0035854) |
1.9 | 5.6 | GO:0090320 | regulation of chylomicron remnant clearance(GO:0090320) |
1.8 | 7.0 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
1.8 | 5.3 | GO:0071626 | mastication(GO:0071626) learned vocalization behavior(GO:0098583) |
1.7 | 8.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.7 | 8.7 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
1.7 | 5.2 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
1.7 | 5.1 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
1.7 | 6.7 | GO:0003017 | lymph circulation(GO:0003017) |
1.6 | 3.3 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
1.6 | 3.3 | GO:0034378 | chylomicron assembly(GO:0034378) |
1.6 | 8.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.6 | 6.5 | GO:0015811 | L-cystine transport(GO:0015811) |
1.5 | 15.2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
1.5 | 4.6 | GO:0051885 | positive regulation of anagen(GO:0051885) |
1.5 | 4.5 | GO:1904582 | positive regulation of intracellular mRNA localization(GO:1904582) |
1.5 | 7.5 | GO:0070543 | response to linoleic acid(GO:0070543) |
1.5 | 5.9 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
1.5 | 4.5 | GO:0042694 | muscle cell fate specification(GO:0042694) |
1.5 | 5.8 | GO:0007522 | visceral muscle development(GO:0007522) |
1.4 | 7.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.4 | 4.3 | GO:0071846 | actin filament debranching(GO:0071846) |
1.4 | 1.4 | GO:1902941 | regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) |
1.4 | 11.0 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
1.4 | 5.5 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
1.3 | 8.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.3 | 3.9 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
1.3 | 6.4 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
1.3 | 5.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.3 | 3.8 | GO:0002414 | immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.3 | 5.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.3 | 3.8 | GO:0021558 | trochlear nerve development(GO:0021558) |
1.2 | 2.5 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
1.2 | 3.7 | GO:1905204 | lung lobe formation(GO:0060464) diaphragm morphogenesis(GO:0060540) negative regulation of connective tissue replacement(GO:1905204) |
1.2 | 3.7 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.2 | 5.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
1.2 | 3.7 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
1.2 | 1.2 | GO:2000662 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
1.2 | 1.2 | GO:1902304 | positive regulation of potassium ion export(GO:1902304) |
1.2 | 3.6 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
1.2 | 3.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.2 | 3.5 | GO:0072347 | response to anesthetic(GO:0072347) |
1.2 | 11.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
1.1 | 2.2 | GO:0046967 | cytosol to ER transport(GO:0046967) |
1.1 | 6.7 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
1.1 | 3.3 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
1.1 | 1.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.1 | 3.3 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.1 | 3.3 | GO:0070839 | divalent metal ion export(GO:0070839) |
1.1 | 1.1 | GO:1902159 | regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) |
1.1 | 7.6 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.1 | 5.4 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
1.1 | 3.2 | GO:0036034 | mediator complex assembly(GO:0036034) DNA replication preinitiation complex assembly(GO:0071163) response to sorbitol(GO:0072708) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
1.1 | 5.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.1 | 7.4 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.1 | 7.4 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
1.1 | 2.1 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
1.0 | 5.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.0 | 3.1 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
1.0 | 6.2 | GO:0048539 | bone marrow development(GO:0048539) |
1.0 | 3.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
1.0 | 2.0 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
1.0 | 3.0 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
1.0 | 4.0 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
1.0 | 1.0 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
1.0 | 3.0 | GO:0046061 | dATP catabolic process(GO:0046061) |
1.0 | 1.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
1.0 | 6.0 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.0 | 5.0 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
1.0 | 3.0 | GO:2000845 | positive regulation of testosterone secretion(GO:2000845) |
1.0 | 11.7 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
1.0 | 2.9 | GO:0032218 | riboflavin transport(GO:0032218) |
1.0 | 1.0 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.0 | 4.8 | GO:0021763 | subthalamic nucleus development(GO:0021763) superior vena cava morphogenesis(GO:0060578) |
1.0 | 9.7 | GO:0015670 | carbon dioxide transport(GO:0015670) |
1.0 | 2.9 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
0.9 | 2.8 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.9 | 0.9 | GO:0060157 | urinary bladder development(GO:0060157) |
0.9 | 11.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.9 | 4.6 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.9 | 2.8 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.9 | 1.8 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.9 | 4.6 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.9 | 3.6 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.9 | 1.8 | GO:0001794 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.9 | 3.6 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.9 | 2.7 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.9 | 2.7 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.9 | 9.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.9 | 2.6 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.9 | 1.7 | GO:0046223 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) |
0.8 | 3.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.8 | 2.5 | GO:0015825 | L-serine transport(GO:0015825) |
0.8 | 1.7 | GO:2000449 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.8 | 3.4 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.8 | 4.2 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.8 | 1.6 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.8 | 3.3 | GO:0030091 | protein repair(GO:0030091) |
0.8 | 3.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.8 | 2.4 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
0.8 | 4.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.8 | 2.4 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.8 | 6.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.8 | 2.4 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
0.8 | 3.1 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.8 | 5.4 | GO:1903232 | melanosome assembly(GO:1903232) |
0.7 | 6.6 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.7 | 5.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.7 | 17.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.7 | 9.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.7 | 6.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.7 | 3.6 | GO:0046449 | creatinine metabolic process(GO:0046449) |
0.7 | 4.4 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.7 | 5.8 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.7 | 2.2 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.7 | 2.9 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.7 | 1.4 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.7 | 18.7 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.7 | 2.8 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.7 | 2.8 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.7 | 3.5 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.7 | 2.1 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.7 | 7.7 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.7 | 2.8 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.7 | 0.7 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.7 | 5.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.7 | 3.5 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.7 | 13.0 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.7 | 4.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.7 | 17.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.7 | 2.0 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.7 | 6.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.7 | 8.8 | GO:0008354 | germ cell migration(GO:0008354) |
0.7 | 2.0 | GO:2000422 | regulation of eosinophil chemotaxis(GO:2000422) positive regulation of eosinophil chemotaxis(GO:2000424) |
0.7 | 7.4 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.7 | 4.7 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.7 | 8.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.7 | 2.7 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.7 | 6.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.7 | 5.3 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.7 | 1.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.7 | 2.6 | GO:0010286 | heat acclimation(GO:0010286) |
0.7 | 2.6 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.7 | 2.6 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.6 | 1.3 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
0.6 | 7.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.6 | 4.5 | GO:0097503 | sialylation(GO:0097503) |
0.6 | 2.6 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.6 | 3.8 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.6 | 5.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.6 | 1.9 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.6 | 1.9 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.6 | 2.5 | GO:1901250 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.6 | 3.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.6 | 1.9 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.6 | 3.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.6 | 1.2 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.6 | 1.8 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.6 | 3.0 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.6 | 3.7 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.6 | 2.4 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.6 | 1.8 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.6 | 1.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.6 | 2.4 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.6 | 1.8 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.6 | 3.6 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.6 | 3.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.6 | 2.4 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.6 | 6.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.6 | 1.2 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.6 | 1.2 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.6 | 1.2 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.6 | 11.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.6 | 1.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.6 | 1.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.6 | 1.1 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.6 | 1.7 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.6 | 1.7 | GO:0061723 | glycophagy(GO:0061723) |
0.6 | 3.4 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.6 | 1.1 | GO:0010039 | response to iron ion(GO:0010039) |
0.6 | 4.5 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.6 | 5.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.6 | 1.7 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.6 | 3.3 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.6 | 2.2 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.6 | 0.6 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.5 | 1.6 | GO:0021759 | globus pallidus development(GO:0021759) |
0.5 | 1.6 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.5 | 5.5 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.5 | 1.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.5 | 1.1 | GO:0070340 | detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
0.5 | 1.1 | GO:1903487 | regulation of lactation(GO:1903487) |
0.5 | 1.6 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.5 | 1.6 | GO:1904631 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) response to diterpene(GO:1904629) cellular response to diterpene(GO:1904630) response to glucoside(GO:1904631) cellular response to glucoside(GO:1904632) |
0.5 | 2.1 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.5 | 4.8 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.5 | 3.2 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.5 | 8.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.5 | 7.4 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.5 | 2.6 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.5 | 0.5 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.5 | 1.6 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.5 | 2.1 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.5 | 1.6 | GO:0019043 | establishment of viral latency(GO:0019043) |
0.5 | 3.6 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.5 | 3.1 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.5 | 1.6 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
0.5 | 1.0 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.5 | 1.5 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.5 | 1.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.5 | 3.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.5 | 2.5 | GO:0035483 | gastric emptying(GO:0035483) |
0.5 | 10.6 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.5 | 1.5 | GO:0060932 | atrioventricular bundle cell differentiation(GO:0003167) His-Purkinje system cell differentiation(GO:0060932) |
0.5 | 1.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.5 | 1.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.5 | 4.5 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.5 | 2.5 | GO:0019516 | lactate oxidation(GO:0019516) |
0.5 | 2.4 | GO:0061056 | sclerotome development(GO:0061056) |
0.5 | 1.5 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.5 | 1.0 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.5 | 1.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.5 | 1.0 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.5 | 1.5 | GO:0060305 | regulation of inositol-polyphosphate 5-phosphatase activity(GO:0010924) positive regulation of inositol-polyphosphate 5-phosphatase activity(GO:0010925) phospholipase C-inhibiting G-protein coupled receptor signaling pathway(GO:0030845) regulation of cell diameter(GO:0060305) |
0.5 | 5.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.5 | 1.4 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.5 | 1.4 | GO:0046203 | spermidine catabolic process(GO:0046203) |
0.5 | 3.8 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.5 | 2.4 | GO:0090383 | phagosome acidification(GO:0090383) |
0.5 | 1.4 | GO:0035801 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) metanephric comma-shaped body morphogenesis(GO:0072278) negative regulation of metanephric glomerulus development(GO:0072299) regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.5 | 1.9 | GO:0072021 | ascending thin limb development(GO:0072021) thick ascending limb development(GO:0072023) metanephric ascending thin limb development(GO:0072218) metanephric thick ascending limb development(GO:0072233) |
0.5 | 3.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.5 | 1.8 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.5 | 2.7 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.5 | 3.6 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.4 | 1.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.4 | 1.3 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
0.4 | 0.9 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.4 | 1.8 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.4 | 2.2 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.4 | 0.4 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.4 | 7.0 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.4 | 1.3 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.4 | 0.4 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.4 | 2.6 | GO:0072718 | response to cisplatin(GO:0072718) |
0.4 | 3.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.4 | 1.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.4 | 12.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.4 | 3.9 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.4 | 3.0 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.4 | 2.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 2.5 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.4 | 2.5 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.4 | 1.7 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.4 | 2.5 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.4 | 1.3 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.4 | 0.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.4 | 0.8 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
0.4 | 3.7 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.4 | 2.5 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.4 | 1.2 | GO:0018900 | dichloromethane metabolic process(GO:0018900) |
0.4 | 2.4 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.4 | 2.9 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.4 | 2.8 | GO:0051013 | microtubule severing(GO:0051013) |
0.4 | 4.8 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.4 | 4.0 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.4 | 3.6 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.4 | 2.8 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.4 | 1.2 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
0.4 | 2.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.4 | 5.9 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.4 | 0.8 | GO:0036166 | phenotypic switching(GO:0036166) |
0.4 | 0.4 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.4 | 0.8 | GO:1900238 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.4 | 2.7 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.4 | 3.1 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.4 | 1.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.4 | 0.8 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.4 | 1.2 | GO:1904093 | regulation of autophagic cell death(GO:1904092) negative regulation of autophagic cell death(GO:1904093) |
0.4 | 10.7 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.4 | 1.9 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.4 | 1.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 6.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.4 | 1.1 | GO:0034240 | negative regulation of macrophage fusion(GO:0034240) |
0.4 | 2.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.4 | 2.6 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.4 | 2.2 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.4 | 2.9 | GO:0018377 | protein myristoylation(GO:0018377) |
0.4 | 2.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.4 | 1.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.4 | 3.3 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.4 | 1.8 | GO:0006548 | histidine catabolic process(GO:0006548) |
0.4 | 1.5 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.4 | 8.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.4 | 2.9 | GO:0033227 | dsRNA transport(GO:0033227) |
0.4 | 2.2 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.4 | 6.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.4 | 1.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.4 | 3.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 1.4 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.4 | 1.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.4 | 3.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.4 | 2.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.4 | 1.1 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.4 | 1.8 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
0.4 | 1.8 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.4 | 6.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.4 | 5.3 | GO:0010226 | response to lithium ion(GO:0010226) |
0.4 | 3.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.4 | 1.8 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.4 | 6.3 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.3 | 1.7 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.3 | 0.3 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.3 | 1.0 | GO:0007308 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.3 | 1.0 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.3 | 3.5 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 3.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.3 | 1.4 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.3 | 1.4 | GO:1902164 | positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.3 | 1.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.3 | 1.7 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.3 | 1.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.3 | 1.4 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.3 | 1.0 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.3 | 1.3 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.3 | 1.7 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 3.3 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.3 | 44.6 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.3 | 2.6 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.3 | 1.6 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 1.0 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.3 | 2.9 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.3 | 1.6 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.3 | 3.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 2.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 4.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.3 | 4.7 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.3 | 3.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 1.6 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.3 | 1.6 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.3 | 11.3 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.3 | 0.6 | GO:0072277 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.3 | 0.6 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.3 | 1.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 1.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 4.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.3 | 1.8 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.3 | 7.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 4.0 | GO:0015747 | urate transport(GO:0015747) |
0.3 | 3.0 | GO:0070836 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.3 | 0.6 | GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
0.3 | 1.5 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.3 | 9.7 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.3 | 1.2 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.3 | 0.6 | GO:1903401 | nitric oxide production involved in inflammatory response(GO:0002537) lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine transport(GO:1902022) L-ornithine transmembrane transport(GO:1903352) L-arginine transmembrane transport(GO:1903400) L-lysine transmembrane transport(GO:1903401) L-lysine import into cell(GO:1903410) arginine transmembrane transport(GO:1903826) |
0.3 | 3.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 0.9 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.3 | 0.6 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.3 | 4.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.3 | 0.6 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.3 | 0.9 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.3 | 0.9 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.3 | 1.2 | GO:0003264 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
0.3 | 1.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.3 | 65.1 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.3 | 2.0 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.3 | 3.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.3 | 3.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 6.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.3 | 2.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.3 | 1.4 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.3 | 1.7 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.3 | 3.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.3 | 2.3 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.3 | 2.0 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.3 | 0.8 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.3 | 1.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 5.4 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.3 | 0.6 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.3 | 4.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.3 | 1.1 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.3 | 1.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.3 | 3.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.3 | 1.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 2.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.3 | 7.9 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.3 | 1.6 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 3.5 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.3 | 8.6 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.3 | 0.3 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
0.3 | 1.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.3 | 2.9 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 0.8 | GO:0070417 | cellular response to cold(GO:0070417) |
0.3 | 1.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 1.9 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 7.7 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.3 | 1.1 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.3 | 3.4 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.3 | 4.2 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.3 | 1.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 2.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.3 | 0.8 | GO:0072363 | regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072363) |
0.3 | 3.1 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 1.0 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 4.3 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.3 | 1.5 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.3 | 1.5 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.3 | 2.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 1.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 0.5 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.2 | 2.2 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 4.7 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 1.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.2 | 1.0 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) cellular response to sodium arsenite(GO:1903936) |
0.2 | 1.2 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.2 | 1.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 3.7 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.2 | 2.0 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 3.9 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 1.0 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.2 | 3.9 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.2 | 1.2 | GO:0007431 | salivary gland development(GO:0007431) |
0.2 | 3.4 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.2 | 1.2 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.2 | 0.7 | GO:1903412 | response to bile acid(GO:1903412) cellular response to bile acid(GO:1903413) |
0.2 | 1.2 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.2 | 1.2 | GO:0021995 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.2 | 6.9 | GO:0080184 | response to phenylpropanoid(GO:0080184) |
0.2 | 1.4 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.2 | 1.7 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 2.6 | GO:0034312 | diol biosynthetic process(GO:0034312) |
0.2 | 1.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 1.2 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.2 | 1.9 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.2 | 1.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 0.7 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.2 | 4.2 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.2 | 7.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 1.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 1.6 | GO:0061709 | reticulophagy(GO:0061709) |
0.2 | 0.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 2.8 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 0.9 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.2 | 0.9 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.2 | 1.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 1.8 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.2 | 2.0 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 2.4 | GO:0043383 | negative T cell selection(GO:0043383) |
0.2 | 3.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 2.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 0.9 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.2 | 2.0 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.2 | 5.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.2 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 1.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 0.9 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 2.6 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.2 | 1.1 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.2 | 1.3 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.2 | 5.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.4 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 2.2 | GO:0035878 | nail development(GO:0035878) |
0.2 | 1.5 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.2 | 0.4 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.2 | 5.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.2 | 0.6 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.2 | 1.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 1.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.2 | 1.0 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.6 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
0.2 | 4.9 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.2 | 4.3 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 0.6 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 0.8 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.2 | 5.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 1.2 | GO:1990839 | response to endothelin(GO:1990839) |
0.2 | 1.2 | GO:0032674 | regulation of interleukin-5 production(GO:0032674) |
0.2 | 0.4 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.2 | 1.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 2.2 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.2 | 1.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 0.8 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.2 | 4.1 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.2 | 10.2 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.2 | 1.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 0.8 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.2 | 1.4 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.2 | 1.4 | GO:0070723 | response to cholesterol(GO:0070723) |
0.2 | 3.5 | GO:0007343 | egg activation(GO:0007343) |
0.2 | 2.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 1.8 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.2 | 0.8 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 1.9 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 2.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.2 | 1.4 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.2 | 1.0 | GO:0002432 | granuloma formation(GO:0002432) |
0.2 | 1.0 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.2 | 1.9 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.2 | 1.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 1.0 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 0.8 | GO:0042637 | catagen(GO:0042637) |
0.2 | 1.7 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 1.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.4 | GO:0045472 | response to ether(GO:0045472) |
0.2 | 0.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 1.1 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.2 | 2.0 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.9 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 2.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.7 | GO:0033367 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
0.2 | 0.5 | GO:0035874 | amiloride transport(GO:0015898) cellular response to copper ion starvation(GO:0035874) response to azide(GO:0097184) cellular response to azide(GO:0097185) |
0.2 | 1.9 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.2 | 2.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 2.6 | GO:0030238 | male sex determination(GO:0030238) |
0.2 | 0.9 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.2 | 1.1 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.2 | 1.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 3.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 1.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 0.5 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.2 | 0.3 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.2 | 2.9 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 2.9 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 1.0 | GO:0019755 | one-carbon compound transport(GO:0019755) |
0.2 | 0.5 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.2 | 1.8 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 0.8 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.2 | 1.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.2 | 1.0 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 0.3 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.2 | 0.2 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.2 | 1.5 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.2 | 0.7 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 0.8 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 1.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.2 | 1.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 1.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.2 | 3.1 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.2 | 1.8 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
0.2 | 1.8 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.2 | 0.2 | GO:0070268 | cornification(GO:0070268) |
0.2 | 3.0 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.2 | 0.9 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 0.5 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 0.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.9 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 1.2 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.2 | 0.8 | GO:0035660 | MyD88-dependent toll-like receptor 4 signaling pathway(GO:0035660) |
0.2 | 1.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.2 | 0.8 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.6 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 0.3 | GO:0044849 | estrous cycle(GO:0044849) |
0.2 | 0.8 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.1 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.1 | 4.8 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.6 | GO:0043096 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.1 | 0.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 6.5 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 3.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.9 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.4 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.1 | 0.3 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.1 | 1.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.6 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.1 | 0.6 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.7 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 1.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.8 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.8 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 1.0 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.8 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.6 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 1.0 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.1 | 0.4 | GO:0006530 | asparagine catabolic process(GO:0006530) |
0.1 | 0.8 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.1 | 1.4 | GO:0034114 | regulation of heterotypic cell-cell adhesion(GO:0034114) |
0.1 | 3.7 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.1 | 1.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.3 | GO:0032902 | nerve growth factor production(GO:0032902) |
0.1 | 2.3 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 1.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.9 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 2.3 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.7 | GO:0046618 | drug export(GO:0046618) |
0.1 | 1.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 1.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.4 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.1 | 0.3 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 0.5 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.7 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.8 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.1 | 0.8 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.8 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 1.0 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 1.3 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.1 | 4.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.8 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
0.1 | 0.4 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.1 | 0.4 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.6 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 1.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 1.9 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.6 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 2.5 | GO:0048536 | spleen development(GO:0048536) |
0.1 | 0.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 1.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.4 | GO:0036245 | cellular response to menadione(GO:0036245) |
0.1 | 1.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.2 | GO:0051695 | actin filament uncapping(GO:0051695) |
0.1 | 1.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 1.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 1.6 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.1 | 2.3 | GO:0044243 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.1 | 0.4 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.1 | 0.5 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 1.4 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.5 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 1.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 1.3 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.7 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 4.4 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.1 | 0.2 | GO:1904868 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.1 | 0.3 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.1 | 2.3 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.2 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 2.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 1.2 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 1.7 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.7 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 1.0 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.1 | 4.9 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 2.2 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 0.3 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.1 | 4.8 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.1 | 0.7 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.1 | 0.1 | GO:1904908 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
0.1 | 1.0 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.4 | GO:0045994 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.1 | 4.8 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 1.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 1.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 1.1 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.1 | 2.7 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.8 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 2.1 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 | 1.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.5 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 0.7 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 1.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.4 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 3.9 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 6.5 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.5 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.1 | 0.9 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 0.4 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.1 | 0.9 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.7 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.8 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 1.9 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.1 | 0.4 | GO:0009814 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.1 | 1.0 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.5 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 1.6 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 1.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 4.1 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.2 | GO:0034756 | regulation of iron ion transport(GO:0034756) negative regulation of iron ion transport(GO:0034757) regulation of iron ion transmembrane transport(GO:0034759) negative regulation of iron ion transmembrane transport(GO:0034760) |
0.1 | 1.9 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 1.3 | GO:0044062 | regulation of excretion(GO:0044062) |
0.1 | 0.6 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 2.7 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.1 | 0.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.9 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 0.2 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
0.1 | 0.8 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.1 | 0.4 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 0.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 1.9 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.1 | 0.6 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.1 | 0.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.1 | GO:0006272 | leading strand elongation(GO:0006272) |
0.1 | 0.6 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 2.2 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.2 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.1 | 0.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 1.6 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.6 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.3 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.9 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.7 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.3 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 3.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.6 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.4 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 1.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.6 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.7 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.1 | 1.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.5 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.1 | 1.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 0.4 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
0.1 | 2.0 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 1.4 | GO:0098751 | bone cell development(GO:0098751) |
0.1 | 0.8 | GO:0007130 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.1 | 0.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 1.3 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.1 | 0.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.6 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 0.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 2.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.5 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.9 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.7 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.5 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.7 | GO:0010458 | exit from mitosis(GO:0010458) |
0.1 | 0.7 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 0.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 0.9 | GO:0006228 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.1 | 0.5 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.4 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.1 | 0.6 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 2.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.6 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 1.5 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.9 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 1.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.5 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 2.9 | GO:1902749 | regulation of cell cycle G2/M phase transition(GO:1902749) |
0.1 | 0.2 | GO:0097065 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.1 | 1.4 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 1.0 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.1 | 0.5 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 0.4 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 0.8 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 1.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.1 | 0.2 | GO:0045141 | meiotic telomere clustering(GO:0045141) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.1 | 0.4 | GO:0006833 | water transport(GO:0006833) |
0.1 | 0.2 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.1 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.3 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.1 | 0.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.3 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 1.0 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.1 | 0.3 | GO:1901509 | ureteric bud elongation(GO:0060677) branch elongation involved in ureteric bud branching(GO:0060681) regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 1.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.4 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.8 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 1.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 1.6 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 3.6 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.1 | 1.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.5 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.6 | GO:0045953 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.1 | 0.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 1.0 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.0 | 0.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 0.4 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.3 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.6 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.6 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) cristae formation(GO:0042407) |
0.0 | 0.6 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.6 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 1.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.7 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.0 | 1.5 | GO:0060323 | head morphogenesis(GO:0060323) face morphogenesis(GO:0060325) |
0.0 | 6.1 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.3 | GO:0033628 | regulation of cell adhesion mediated by integrin(GO:0033628) |
0.0 | 0.5 | GO:1904705 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.0 | 1.0 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.0 | 0.4 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.0 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.0 | 0.3 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.2 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 1.6 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.0 | 0.5 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.7 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.9 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.2 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 | 0.2 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 2.3 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.0 | 0.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.8 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.5 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.2 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.0 | 0.9 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 1.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.0 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.5 | GO:0048538 | thymus development(GO:0048538) |
0.0 | 0.5 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
0.0 | 1.3 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.3 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.0 | 0.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.9 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.2 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.0 | 0.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.0 | 0.2 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.2 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
0.0 | 0.1 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.0 | 0.0 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.0 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.3 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.6 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.0 | 0.3 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.0 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 1.5 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.0 | 0.5 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.0 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
0.0 | 0.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.3 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.0 | 0.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.6 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
1.8 | 21.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
1.8 | 7.3 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
1.7 | 3.3 | GO:0044317 | rod spherule(GO:0044317) |
1.6 | 1.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.5 | 6.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.3 | 1.3 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
1.3 | 7.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.2 | 3.6 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
1.2 | 10.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.1 | 15.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.0 | 9.4 | GO:1990357 | terminal web(GO:1990357) |
1.0 | 18.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.0 | 5.0 | GO:0045160 | myosin I complex(GO:0045160) |
1.0 | 5.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.0 | 2.9 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
0.9 | 2.8 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.9 | 2.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.9 | 5.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.9 | 11.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.9 | 0.9 | GO:0005839 | proteasome core complex(GO:0005839) |
0.9 | 4.4 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
0.8 | 3.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.8 | 1.6 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.8 | 3.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.8 | 2.3 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.7 | 5.2 | GO:0071914 | prominosome(GO:0071914) |
0.7 | 2.2 | GO:0034359 | mature chylomicron(GO:0034359) |
0.7 | 9.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.6 | 2.5 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.6 | 2.5 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.6 | 1.8 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.6 | 5.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.6 | 1.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.6 | 6.9 | GO:0000796 | condensin complex(GO:0000796) |
0.6 | 2.9 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.6 | 4.5 | GO:0042825 | TAP complex(GO:0042825) |
0.6 | 1.7 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.6 | 2.8 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.6 | 2.8 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.5 | 8.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.5 | 2.7 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.5 | 2.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.5 | 6.7 | GO:0036156 | inner dynein arm(GO:0036156) |
0.5 | 2.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.5 | 1.5 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.5 | 1.5 | GO:0002140 | stereocilia tip link(GO:0002140) myosin VII complex(GO:0031477) stereocilia tip-link density(GO:1990427) upper tip-link density(GO:1990435) |
0.5 | 13.7 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.5 | 2.9 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.5 | 1.0 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.5 | 2.9 | GO:0070820 | tertiary granule(GO:0070820) |
0.5 | 1.9 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.5 | 1.4 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.5 | 9.3 | GO:0016580 | Sin3 complex(GO:0016580) |
0.5 | 14.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.5 | 1.4 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.5 | 7.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 2.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.4 | 4.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 6.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 2.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.4 | 1.3 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.4 | 2.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.4 | 6.8 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 51.8 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.4 | 1.3 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.4 | 1.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 9.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.4 | 7.0 | GO:0090543 | Flemming body(GO:0090543) |
0.4 | 3.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.4 | 2.4 | GO:0008278 | cohesin complex(GO:0008278) |
0.4 | 1.6 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.4 | 7.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.4 | 4.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.4 | 7.7 | GO:0042581 | specific granule(GO:0042581) |
0.4 | 1.1 | GO:0014801 | longitudinal sarcoplasmic reticulum(GO:0014801) |
0.4 | 1.5 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.4 | 7.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.4 | 2.6 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.4 | 2.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 3.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.4 | 1.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 1.1 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.4 | 1.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.4 | 4.2 | GO:0043219 | lateral loop(GO:0043219) |
0.3 | 5.8 | GO:0042627 | chylomicron(GO:0042627) |
0.3 | 1.0 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.3 | 9.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.3 | 1.7 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 2.3 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 2.6 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.3 | 4.9 | GO:0044754 | autolysosome(GO:0044754) |
0.3 | 3.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 3.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 1.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 4.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 4.1 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 1.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 8.8 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 0.9 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.3 | 1.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 1.4 | GO:0031251 | PAN complex(GO:0031251) |
0.3 | 0.8 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.3 | 1.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.3 | 1.1 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.3 | 1.0 | GO:0001740 | X chromosome(GO:0000805) Barr body(GO:0001740) |
0.3 | 3.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 1.8 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 1.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.3 | 29.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.3 | 1.8 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 6.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 1.5 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 0.9 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.2 | 4.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 3.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 0.9 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.2 | 9.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 1.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 1.1 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.2 | 1.6 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 0.7 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 1.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 2.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.8 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.2 | 1.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 0.8 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.2 | 16.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 0.6 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.2 | 0.6 | GO:0060473 | cortical granule(GO:0060473) |
0.2 | 2.8 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 2.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 3.7 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 1.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 1.4 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.6 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.2 | 2.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 1.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 1.9 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 67.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 16.9 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 2.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 0.7 | GO:1990037 | Lewy body core(GO:1990037) |
0.2 | 5.6 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 0.7 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 2.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 1.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 5.6 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 5.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 1.7 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 4.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 1.0 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.2 | 1.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 0.8 | GO:0035841 | new growing cell tip(GO:0035841) |
0.2 | 1.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 1.5 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 0.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 4.2 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.1 | 0.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 5.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 1.4 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 2.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 6.1 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.1 | 0.8 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 1.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 1.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 5.1 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 3.2 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 1.5 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 1.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 26.2 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 3.8 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 1.0 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 2.1 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.9 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 76.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 2.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 8.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.6 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 2.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.6 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.8 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.1 | 0.3 | GO:0018444 | translation release factor complex(GO:0018444) |
0.1 | 0.9 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 1.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 1.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 6.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 1.0 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.1 | 2.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 2.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.4 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 4.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 5.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 13.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.5 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 0.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 1.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 48.9 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 18.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 1.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 4.8 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 6.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 1.8 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 3.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 3.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.8 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 1.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 4.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.2 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.3 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
0.1 | 2.8 | GO:0001741 | XY body(GO:0001741) |
0.1 | 1.0 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 17.9 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.4 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.5 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.5 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.9 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 6.8 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.1 | GO:0005715 | late recombination nodule(GO:0005715) |
0.1 | 0.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 0.9 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 2.5 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 1.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 2.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 1.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 5.9 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 93.2 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 3.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 1.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.5 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.5 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.3 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 6.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 4.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 7.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 1.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.4 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 5.2 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.7 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.5 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 0.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 1.6 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 6.4 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 1.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 2.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 4.4 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.6 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 2.7 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.0 | 1.9 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.1 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.0 | 1.6 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.0 | 1.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 3.0 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 0.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.1 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.6 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.3 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 0.2 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.0 | 0.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 28.4 | GO:0005576 | extracellular region(GO:0005576) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.7 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
2.5 | 7.6 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
2.1 | 6.2 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
2.0 | 13.9 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
2.0 | 9.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
1.7 | 5.0 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.6 | 6.5 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
1.6 | 4.9 | GO:0050785 | advanced glycation end-product receptor activity(GO:0050785) |
1.6 | 6.5 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
1.5 | 7.5 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
1.3 | 5.1 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.2 | 3.7 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
1.2 | 7.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.2 | 4.7 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
1.1 | 5.7 | GO:0035478 | chylomicron binding(GO:0035478) |
1.1 | 4.4 | GO:0070976 | TIR domain binding(GO:0070976) |
1.1 | 3.2 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
1.0 | 7.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
1.0 | 7.1 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
1.0 | 4.0 | GO:0004096 | catalase activity(GO:0004096) |
1.0 | 4.0 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.0 | 1.0 | GO:0045340 | mercury ion binding(GO:0045340) |
1.0 | 2.9 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
1.0 | 5.8 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
1.0 | 3.8 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.9 | 2.8 | GO:0008396 | oxysterol 7-alpha-hydroxylase activity(GO:0008396) |
0.9 | 15.8 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.9 | 2.8 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
0.9 | 14.7 | GO:1990405 | protein antigen binding(GO:1990405) |
0.9 | 10.1 | GO:0015250 | water channel activity(GO:0015250) |
0.9 | 2.7 | GO:0071820 | N-box binding(GO:0071820) |
0.9 | 2.7 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.9 | 5.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.9 | 2.6 | GO:0008456 | alpha-N-acetylgalactosaminidase activity(GO:0008456) |
0.8 | 5.9 | GO:1990254 | keratin filament binding(GO:1990254) |
0.8 | 7.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.8 | 10.8 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.8 | 7.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.8 | 4.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.8 | 2.4 | GO:0036461 | BLOC-2 complex binding(GO:0036461) |
0.8 | 3.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.8 | 6.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.8 | 3.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.8 | 2.4 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.8 | 2.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.8 | 3.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.8 | 2.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.8 | 2.3 | GO:0002061 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) |
0.7 | 5.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.7 | 9.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 2.9 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
0.7 | 2.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.7 | 3.5 | GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
0.7 | 4.2 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.7 | 2.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.7 | 2.1 | GO:0070540 | stearic acid binding(GO:0070540) |
0.7 | 9.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.7 | 2.8 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.7 | 2.0 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.7 | 3.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.7 | 2.6 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.7 | 3.3 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.6 | 1.9 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.6 | 2.6 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.6 | 3.2 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.6 | 3.8 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.6 | 2.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.6 | 1.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.6 | 1.8 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.6 | 1.8 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.6 | 1.8 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.6 | 10.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.6 | 4.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.6 | 3.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.6 | 4.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.6 | 3.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.5 | 6.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.5 | 3.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.5 | 4.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 2.7 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.5 | 2.2 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.5 | 3.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.5 | 10.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.5 | 2.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.5 | 2.1 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.5 | 2.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.5 | 2.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.5 | 3.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 1.0 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.5 | 1.6 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
0.5 | 2.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.5 | 3.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.5 | 1.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.5 | 1.5 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.5 | 3.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.5 | 2.5 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.5 | 1.9 | GO:0047016 | cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity(GO:0047016) |
0.5 | 1.5 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
0.5 | 1.4 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.5 | 2.4 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.5 | 4.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.5 | 5.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.5 | 4.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.5 | 2.3 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.5 | 1.4 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.5 | 12.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 2.8 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.5 | 10.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.5 | 6.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.5 | 4.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.5 | 1.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.5 | 23.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.4 | 1.3 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.4 | 1.8 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.4 | 4.0 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.4 | 5.8 | GO:0046790 | virion binding(GO:0046790) |
0.4 | 1.7 | GO:0019809 | spermidine binding(GO:0019809) |
0.4 | 1.3 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.4 | 55.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.4 | 1.7 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.4 | 1.7 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.4 | 10.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.4 | 2.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.4 | 1.3 | GO:0033971 | hydroxyisourate hydrolase activity(GO:0033971) |
0.4 | 2.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 2.9 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.4 | 4.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.4 | 2.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.4 | 1.2 | GO:0070122 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.4 | 1.2 | GO:0016824 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.4 | 2.9 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 2.4 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.4 | 9.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.4 | 1.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 6.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 2.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.4 | 5.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 3.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.4 | 2.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.4 | 3.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 1.2 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.4 | 1.9 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.4 | 2.7 | GO:0030172 | troponin C binding(GO:0030172) |
0.4 | 5.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 2.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 1.9 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 3.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.4 | 3.3 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.4 | 4.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 3.7 | GO:0019864 | IgG binding(GO:0019864) |
0.4 | 4.0 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.4 | 2.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.4 | 7.8 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.4 | 1.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.4 | 1.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 1.0 | GO:0002055 | adenine binding(GO:0002055) adenine phosphoribosyltransferase activity(GO:0003999) |
0.3 | 1.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 2.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 3.1 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 1.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 1.7 | GO:2001070 | starch binding(GO:2001070) |
0.3 | 2.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 1.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 3.7 | GO:0051870 | methotrexate binding(GO:0051870) |
0.3 | 1.0 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.3 | 1.0 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.3 | 8.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 1.0 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.3 | 0.3 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.3 | 5.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.3 | 1.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.3 | 1.0 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.3 | 1.3 | GO:0051435 | BH4 domain binding(GO:0051435) |
0.3 | 16.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 0.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 0.9 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.3 | 0.9 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.3 | 11.9 | GO:0043236 | laminin binding(GO:0043236) |
0.3 | 0.3 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.3 | 1.2 | GO:0019213 | deacetylase activity(GO:0019213) |
0.3 | 3.0 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 1.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.3 | 4.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 1.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 1.2 | GO:0018455 | alcohol dehydrogenase [NAD(P)+] activity(GO:0018455) |
0.3 | 7.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.3 | 2.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.3 | 1.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 0.6 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.3 | 1.2 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.3 | 5.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 0.9 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.3 | 1.1 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.3 | 3.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.3 | 1.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 2.5 | GO:0004875 | complement receptor activity(GO:0004875) |
0.3 | 2.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 2.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 1.4 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.3 | 7.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 2.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 2.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.3 | 1.9 | GO:0032052 | bile acid binding(GO:0032052) |
0.3 | 1.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 1.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 4.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.3 | 14.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 4.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.3 | 0.5 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 1.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 1.6 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 0.8 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.3 | 4.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 3.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 0.8 | GO:0042602 | riboflavin reductase (NADPH) activity(GO:0042602) |
0.3 | 1.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 7.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 1.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.3 | 1.3 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.3 | 0.5 | GO:0070401 | NADP+ binding(GO:0070401) |
0.3 | 5.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 4.9 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 6.7 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 0.8 | GO:0016034 | maleylacetoacetate isomerase activity(GO:0016034) |
0.3 | 2.8 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.3 | 6.3 | GO:0004601 | peroxidase activity(GO:0004601) |
0.3 | 0.8 | GO:0008775 | acetate CoA-transferase activity(GO:0008775) |
0.3 | 2.0 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.2 | 2.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 1.7 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.2 | 3.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 3.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 5.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.7 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.7 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 1.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 3.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 0.7 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 19.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 2.5 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 1.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.2 | 0.7 | GO:0001096 | TFIIF-class transcription factor binding(GO:0001096) |
0.2 | 1.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 0.9 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 4.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 2.4 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.2 | 19.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 0.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 1.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 3.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 1.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 1.5 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.2 | 0.6 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.2 | 2.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 1.5 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 5.3 | GO:0008009 | chemokine activity(GO:0008009) |
0.2 | 0.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.2 | 0.6 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 0.6 | GO:0070002 | glutamic-type peptidase activity(GO:0070002) |
0.2 | 1.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 3.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.6 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
0.2 | 1.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 1.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 23.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 1.0 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 0.4 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.2 | 6.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.2 | 2.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.2 | 8.8 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 2.5 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 1.0 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.2 | 3.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 0.6 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.2 | 10.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 2.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 8.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 7.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 1.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 5.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 2.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 5.6 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.2 | 1.8 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 8.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 0.5 | GO:0052597 | diamine oxidase activity(GO:0052597) histamine oxidase activity(GO:0052598) methylputrescine oxidase activity(GO:0052599) propane-1,3-diamine oxidase activity(GO:0052600) |
0.2 | 1.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 2.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 1.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 0.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 0.5 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 1.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 37.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 1.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 0.7 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.2 | 1.9 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 7.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 1.0 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.2 | 1.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 1.7 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.2 | 1.0 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.2 | 2.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 1.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.2 | 2.0 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.2 | 1.8 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.2 | 1.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 1.0 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.2 | 1.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 7.0 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 0.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 10.5 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 0.5 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.2 | 0.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 0.6 | GO:0005118 | sevenless binding(GO:0005118) |
0.2 | 5.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 0.6 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.2 | 1.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 0.8 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 1.2 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 1.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 1.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 1.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.6 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.4 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
0.1 | 2.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 1.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 1.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.6 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.1 | 3.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 1.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 1.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 1.5 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 1.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.8 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.1 | 1.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.6 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.1 | 8.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 2.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 3.8 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 1.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.5 | GO:0032093 | SAM domain binding(GO:0032093) |
0.1 | 5.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 3.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 2.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.4 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.1 | 5.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 2.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 5.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 8.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 6.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 4.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.5 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 3.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.8 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.4 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 1.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.9 | GO:0050308 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.1 | 0.8 | GO:0032357 | oxidized purine DNA binding(GO:0032357) |
0.1 | 1.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 1.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.1 | 0.6 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
0.1 | 4.1 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 3.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 1.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 1.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.4 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.1 | 1.1 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.1 | 0.7 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 1.0 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.1 | 1.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 1.2 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 1.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 1.1 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 0.8 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 1.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.9 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 1.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.7 | GO:0003917 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.5 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.1 | 2.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 6.5 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 1.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 1.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 1.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) U7 snRNA binding(GO:0071209) |
0.1 | 2.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 2.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 2.4 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 5.7 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 1.2 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.7 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 1.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 1.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.7 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 5.2 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 1.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.8 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.7 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.4 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.1 | 1.8 | GO:0070001 | aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.4 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.1 | 3.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 1.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.3 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.1 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 16.3 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 0.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.6 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 1.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 1.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 2.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 1.4 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 31.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.5 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) |
0.1 | 1.7 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.1 | 0.2 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 1.0 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) fatty acid ligase activity(GO:0015645) decanoate--CoA ligase activity(GO:0102391) |
0.1 | 4.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.2 | GO:0001607 | neuromedin U receptor activity(GO:0001607) |
0.1 | 0.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 4.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 13.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 6.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 1.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 1.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 1.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.3 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.1 | 1.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 1.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 5.6 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 0.8 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 4.5 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 0.5 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 1.6 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.6 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 3.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.2 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.9 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.1 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.1 | 1.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.4 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 3.8 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 2.6 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 29.1 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 1.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 1.0 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.1 | 0.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 1.5 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.9 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 2.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 2.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.1 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 1.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 1.3 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.0 | 0.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.4 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.0 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.2 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.0 | 0.6 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.2 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.0 | 0.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.6 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.3 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 3.2 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 1.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.1 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.0 | 0.1 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.0 | 0.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.1 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
0.0 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 4.3 | GO:0061134 | peptidase regulator activity(GO:0061134) |
0.0 | 2.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 13.4 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.0 | 0.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.1 | GO:0004001 | adenosine kinase activity(GO:0004001) |
0.0 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.1 | GO:0016872 | inositol-3-phosphate synthase activity(GO:0004512) intramolecular lyase activity(GO:0016872) |
0.0 | 0.5 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.9 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.1 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.0 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.0 | 0.7 | GO:0051087 | chaperone binding(GO:0051087) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 5.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.6 | 15.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.6 | 9.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 5.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.5 | 8.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 3.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.5 | 8.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 6.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.4 | 4.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 4.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.4 | 23.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.4 | 3.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 0.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 29.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 10.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.3 | 3.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 22.7 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 24.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 9.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 1.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 0.3 | ST ADRENERGIC | Adrenergic Pathway |
0.3 | 6.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 9.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 5.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 13.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 3.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.3 | 8.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 4.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 12.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 3.3 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 6.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 3.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 17.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 1.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 18.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 6.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 3.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 6.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 2.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 7.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 10.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 15.1 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 2.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 2.9 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 5.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 5.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 11.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 7.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 1.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 0.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 1.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 1.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 10.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 3.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 2.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 3.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 8.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 3.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 1.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 4.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 9.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 4.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 9.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 2.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 3.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 10.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 20.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 5.5 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 2.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 1.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 15.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 4.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 2.6 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 3.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 2.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 2.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 1.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 2.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 5.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 3.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 1.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.2 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 1.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 1.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 1.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 24.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.0 | 39.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.0 | 3.8 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.9 | 18.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.8 | 0.8 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.7 | 2.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 12.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.5 | 11.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.5 | 6.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.4 | 7.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 0.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 8.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 4.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 9.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.4 | 2.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.4 | 25.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 3.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 5.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 6.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 6.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 13.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 4.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.3 | 4.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.3 | 8.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 5.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.3 | 5.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 11.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 3.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 5.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 2.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.3 | 0.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.3 | 3.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 3.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 4.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 1.1 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.3 | 5.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 1.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.3 | 11.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 4.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 16.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 0.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 0.7 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.2 | 19.2 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 4.6 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 5.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 3.9 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 0.9 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 9.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 1.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 6.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 8.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 1.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 2.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 1.1 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 1.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 5.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 9.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 9.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 3.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 0.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 1.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 2.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 1.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 2.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 3.5 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 3.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 1.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 2.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 4.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 1.7 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 3.9 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 4.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 4.6 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 2.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 7.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.7 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 3.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 2.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 15.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.9 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 5.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.3 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 1.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 3.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 3.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.7 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 2.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 2.0 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 3.2 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 2.5 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 3.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 2.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 5.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 3.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 0.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 1.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 3.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 2.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 1.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 3.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.6 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 4.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 2.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.6 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 3.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 1.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 2.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 1.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 10.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 2.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 3.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 8.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 2.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 0.8 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 0.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.4 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 1.4 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.4 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 2.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 2.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 1.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 3.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 1.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.9 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 0.3 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.3 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.3 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 1.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 2.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 1.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 4.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.5 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |